Lowe Brockenbrough & Co’s AtriCure ATRC Stock Holding History

Lowe Brockenbrough & Co’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-7,000	Closed	-$213K	–	259
2024 Q1	$213K	Buy	+7,000	New	+$234K	0.01%	257
2023 Q4	–	Sell	-7,000	Closed	-$307K	–	258
2023 Q3	$307K	Hold	7,000	–	–	0.02%	239
2023 Q2	$346K	Hold	7,000	–	–	0.03%	237
2023 Q1	$290K	Buy	+7,000	New	+$290K	0.02%	239
2022 Q4	–	Sell	-7,000	Closed	-$274K	–	261
2022 Q3	$274K	Hold	7,000	–	–	0.03%	232
2022 Q2	$286K	Hold	7,000	–	–	0.03%	236
2022 Q1	$460K	Hold	7,000	–	–	0.03%	216
2021 Q4	$487K	Sell	7,000 -369	-5%	-$26.8K	0.04%	200
2021 Q3	$513K	Buy	+7,369	New	+$567K	0.04%	209

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lowe Brockenbrough & Co's ATRC Position: Q2 2024 in Review

Lowe Brockenbrough & Co sold out of AtriCure (ATRC) in Q2 2024, closing a stake of 7,000 shares — an estimated $213K sold.

Lowe Brockenbrough & Co first reported a position in ATRC in Q3 2021 and held it in 9 quarters. The position peaked at $513K in Q3 2021. 197 funds tracked by Wall St. Rank hold ATRC as of Q2 2024.

Lowe Brockenbrough & Co reported no remaining AtriCure position as of Q2 2024 after selling out during the quarter.
Lowe Brockenbrough & Co sold 7,000 AtriCure shares in Q2 2024, an estimated $213K.
Lowe Brockenbrough & Co first reported a position in AtriCure in Q3 2021 and held it in 9 quarters.
Lowe Brockenbrough & Co's AtriCure position peaked at $513K in Q3 2021.
197 funds tracked by Wall St. Rank held AtriCure as of Q2 2024.

Based on Lowe Brockenbrough & Co's 13F filing for Q2 2024, filed 12 Aug 2024.